Skip to main content

[New post] Meissa Vaccines Begins Study of RSV Vaccine Candidate in Seronegative Children

Daniel Webster posted: " REDWOOD CITY, Calif.--(BUSINESS WIRE)--Meissa Vaccines ("Meissa"), a biotechnology company developing vaccines to prevent serious viral respiratory infections, announced today the first seronegative participants have received MV-012-968, Meissa's"

Comments

Popular posts from this blog

Melinda Gates reportedly consulted with divorce lawyers since 2019

[New post] STUNNING: Magnetized Threads Weave Spectacular Galactic Tapestry

Top No-Code Tools to Automate Your Approval Process